Ena Oru is an Executive Director at Eli Lilly and Company, focusing on Diabetes, Obesity, and Cardiometabolic Diseases Clinical Development. With a medical background, Ena has held various roles in health and life sciences, including a Medical Doctor at National Hospital and a Fellow at Gates Ventures. Their experience also includes consulting for the World Health Organization and leading health initiatives at the Clinton Health Access Initiative. Ena holds an MD from Windsor University, an MPH from Columbia University, and an MBA from MIT Sloan School of Management, where they have also served as a Teaching Associate. Currently, Ena is an MIT Sloan Alumni Board Member.
This person is not in any teams
This person is not in any offices